Metsera gets higher bids from Novartis, Pfizer in bidding war

4 hours ago 1
Selection of weight loss drugs

Douglas Cliff

Metsera (MTSR) received higher offers from Pfizer (PFE) and Novo Nordisk (NVO) in a bidding war for the obesity drugmaker.

Metsera (MTSR) said that Novo Nordisk's (NVO) bid is still superior to Pfizer's (PFE), according

Recommended For You

More Trending News

Read Entire Article